PAQ Therapeutics
About PAQ Therapeutics
A biotechnology company developing KRAS degraders for deadly cancers without good treatment options.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
Founders
No founder information available.
Investors
No investor information available.
Recent Mentions
New Raise 🏛️ Company: PAQ Therapeutics 🔗 Website: https://t.co/vN8PC1M3Ja 📊 Amount: $39 Million 🔄 Round: Series B 🧮 Valuation: N/A ⚙️ Industry: Biotechnology
PAQ Therapeutics, a Burlington, MA-based biotechnology company developing KRAS degraders, raised $39M in Series B funding https://t.co/LAahUDLIkD
We're thrilled to celebrate HAYA Therapeutics’ impressive $65M Series A round, made to advance their RNA-guided therapeutics platform! 🔬 https://t.co/cf2XZABz1T With this funding, HAYA, which was ranked among the TOP 100 Swiss Startups Award for 5 consecutive years, and https://t.co/Fi94cVovXQ
New Raise 🏛️ Company: HAYA Therapeutics 🔗 Website: https://t.co/ijdwfnbvoH 📊 Amount: $65 Million 🔄 Round: Series A 🧮 Valuation: N/A ⚙️ Industry: Biotechnology
Similar Startups
ProteinQure
86% matchProteinQure is a biotechnology startup focused on revolutionizing the design and optimization of pro...
AusperBio
85% matchA clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.
BioTroy Therapeutics
84% matchBioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...
Alpheus Medical
84% matchA private, clinical-stage oncology company focused on developing innovative therapies for cancer tre...